Search the site

News & Events

Extra whooping cough shots to protect bubs

An extra whooping cough vaccination for babies comes as a result of work by researchers at the Wesfarmers Centre of Vaccines and Infectious Diseases.

News & Events

The Kids researcher named WA Youth Awards finalist

25 year old Noongar woman Tiana Culbong, a The Kids Research Institute Australia researcher, has been named as a finalist in the WA Youth Awards.

News & Events

New research into multiple sclerosis & vitamin D

Researchers at Perth's The Kids Research Institute Australia have begun a study that could provide new insights into the role of vitamin D in the risk of multiple sclerosis (

News & Events

Hormones in utero influence facial structure

Hormone levels in the womb may determine how masculine or feminine your facial features are as an adult, The Kids Research Institute Australia researchers have found.

News & Events

Outdoor play

Have you ever wondered what impact the design of your backyard and the design of your neighbourhood is having on the health of your kids?

News & Events

Aussie Kids to Benefit from Research Focus

Enhancing the lives of Australian children is the focus of The Fraser Mustard Centre, a collaboration bringing scientists and government together.

News & Events

Study finds folate protects against childhood brain tumours

A national study led by Perth's Telethon Institute has found that folic acid supplements before and during pregnancy reduces the risk of childhood brain tumours

News & Events

Fiona Stanley to retire as Institute Director

The Board of The Kids for Child Health Research tonight announced at its AGM that Professor Fiona Stanley would retire as Director

News & Events

Continuing the cancer fight

Work by the Institute's Division of Children's Leukaemia and Cancer Research has been recognised with three research grants from the Cancer Council of WA.

Research

Use of bevacizumab as a single agent or in adjunct with traditional chemotherapy regimens in children with unresectable or progressive low-grade glioma

Bevacizumab is well tolerated and appears most effective for rapid tumor control to preserve vision and improve morbidity